These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35014183)

  • 1. Intensive care unit-acquired weakness and the COVID-19 pandemic: A clinical review.
    Qin ES; Hough CL; Andrews J; Bunnell AE
    PM R; 2022 Feb; 14(2):227-238. PubMed ID: 35014183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive Care Unit- Acquired Weakness and Hospital Functional Mobility Outcomes Following Invasive Mechanical Ventilation in Patients with COVID-19: A Single-Centre Prospective Cohort Study.
    Núñez-Seisdedos MN; Lázaro-Navas I; López-González L; López-Aguilera L
    J Intensive Care Med; 2022 Aug; 37(8):1005-1014. PubMed ID: 35578542
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical review: intensive care unit acquired weakness.
    Hermans G; Van den Berghe G
    Crit Care; 2015 Aug; 19(1):274. PubMed ID: 26242743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Care Unit-Acquired Weakness: Not just Another Muscle Atrophying Condition.
    Lad H; Saumur TM; Herridge MS; Dos Santos CC; Mathur S; Batt J; Gilbert PM
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive care unit-acquired weakness.
    Horn J; Hermans G
    Handb Clin Neurol; 2017; 141():531-543. PubMed ID: 28190434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive Care Unit-Acquired Weakness in Patients With COVID-19: Occurrence and Associated Factors.
    Schmidt D; Piva TC; Glaeser SS; Piekala DM; Berto PP; Friedman G; Sbruzzi G
    Phys Ther; 2022 May; 102(5):. PubMed ID: 35233607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlactacidemia as a risk factor for intensive care unit-acquired weakness in critically ill adult patients.
    Yang T; Li Z; Jiang L; Xi X
    Muscle Nerve; 2021 Jul; 64(1):77-82. PubMed ID: 33831220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults.
    Fan E; Cheek F; Chlan L; Gosselink R; Hart N; Herridge MS; Hopkins RO; Hough CL; Kress JP; Latronico N; Moss M; Needham DM; Rich MM; Stevens RD; Wilson KC; Winkelman C; Zochodne DW; Ali NA; ;
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1437-46. PubMed ID: 25496103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Time Course and Influence on Quality of Life of Intensive Care Unit-Acquired Weakness Symptoms in Long-Term Intensive Care Survivors.
    Meyer-Frießem CH; Malewicz NM; Rath S; Ebel M; Kaisler M; Tegenthoff M; Schildhauer TA; Pogatzki-Zahn EM; Maier C; Zahn PK
    J Intensive Care Med; 2021 Nov; 36(11):1313-1322. PubMed ID: 32799703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive Care Unit-Acquired Weakness.
    Kramer CL
    Neurol Clin; 2017 Nov; 35(4):723-736. PubMed ID: 28962810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular involvement in COVID-19 critically ill patients.
    Cabañes-Martínez L; Villadóniga M; González-Rodríguez L; Araque L; Díaz-Cid A; Ruz-Caracuel I; Pian H; Sánchez-Alonso S; Fanjul S; Del Álamo M; Regidor I
    Clin Neurophysiol; 2020 Dec; 131(12):2809-2816. PubMed ID: 33137571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICU-Acquired Weakness.
    Jolley SE; Bunnell AE; Hough CL
    Chest; 2016 Nov; 150(5):1129-1140. PubMed ID: 27063347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICU-Acquired Weakness: A Rehabilitation Perspective of Diagnosis, Treatment, and Functional Management.
    Zorowitz RD
    Chest; 2016 Oct; 150(4):966-971. PubMed ID: 27312737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-COVID-19 Intensive Care Unit-Acquired Weakness Compromises Long-Term Functional Status.
    Schmidt D; Margarites AG; Alvarenga LPKB; Paesi PM; Friedman G; Sbruzzi G
    Phys Ther; 2023 Dec; 103(12):. PubMed ID: 37658771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fitness and mobility training in patients with Intensive Care Unit-acquired muscle weakness (FITonICU): study protocol for a randomised controlled trial.
    Mehrholz J; Thomas S; Burridge JH; Schmidt A; Scheffler B; Schellin R; Rückriem S; Meißner D; Mehrholz K; Sauter W; Bodechtel U; Elsner B
    Trials; 2016 Nov; 17(1):559. PubMed ID: 27881152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol as a Risk Factor for ICU-Acquired Weakness in Septic Patients with Acute Respiratory Failure.
    Abdelmalik PA; Rakocevic G
    Can J Neurol Sci; 2017 May; 44(3):295-303. PubMed ID: 28091345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional ability and quality of life in critical illness survivors with intensive care unit acquired weakness: A secondary analysis of a randomised controlled trial.
    Eggmann S; Luder G; Verra ML; Irincheeva I; Bastiaenen CHG; Jakob SM
    PLoS One; 2020; 15(3):e0229725. PubMed ID: 32131082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes.
    Latronico N; Rasulo FA; Eikermann M; Piva S
    Crit Care; 2023 Nov; 27(1):439. PubMed ID: 37957759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.
    Bax F; Lettieri C; Marini A; Pellitteri G; Surcinelli A; Valente M; Budai R; Patruno V; Gigli GL
    Neurol Sci; 2021 Jun; 42(6):2173-2178. PubMed ID: 33755815
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.